Structure

Physi-Chem Properties

Molecular Weight:  884.48
Volume:  856.665
LogP:  2.673
LogD:  1.396
LogS:  -3.684
# Rotatable Bonds:  7
TPSA:  255.91
# H-Bond Aceptor:  17
# H-Bond Donor:  9
# Rings:  9
# Heavy Atoms:  17

MedChem Properties

QED Drug-Likeness Score:  0.157
Synthetic Accessibility Score:  6.836
Fsp3:  0.956
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.94
MDCK Permeability:  0.00020781232160516083
Pgp-inhibitor:  0.52
Pgp-substrate:  0.998
Human Intestinal Absorption (HIA):  0.96
20% Bioavailability (F20%):  0.007
30% Bioavailability (F30%):  0.87

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.011
Plasma Protein Binding (PPB):  72.69743347167969%
Volume Distribution (VD):  0.124
Pgp-substrate:  6.595242977142334%

ADMET: Metabolism

CYP1A2-inhibitor:  0.002
CYP1A2-substrate:  0.946
CYP2C19-inhibitor:  0.007
CYP2C19-substrate:  0.448
CYP2C9-inhibitor:  0.001
CYP2C9-substrate:  0.003
CYP2D6-inhibitor:  0.002
CYP2D6-substrate:  0.093
CYP3A4-inhibitor:  0.044
CYP3A4-substrate:  0.019

ADMET: Excretion

Clearance (CL):  0.621
Half-life (T1/2):  0.684

ADMET: Toxicity

hERG Blockers:  0.747
Human Hepatotoxicity (H-HT):  0.209
Drug-inuced Liver Injury (DILI):  0.218
AMES Toxicity:  0.325
Rat Oral Acute Toxicity:  0.48
Maximum Recommended Daily Dose:  0.307
Skin Sensitization:  0.944
Carcinogencity:  0.327
Eye Corrosion:  0.003
Eye Irritation:  0.008
Respiratory Toxicity:  0.983

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC469345

Natural Product ID:  NPC469345
Common Name*:   Secalonic Acid D
IUPAC Name:   n.a.
Synonyms:   Secalonic Acid D
Standard InCHIKey:  IODWZVMVQOCZTC-NHBPCGONSA-N
Standard InCHI:  InChI=1S/C32H32O14/c1-11-9-15(33)21-25(37)19-17(45-31(21,27(11)39)29(41)43-3)7-5-13(23(19)35)14-6-8-18-20(24(14)36)26(38)22-16(34)10-12(2)28(40)32(22,46-18)30(42)44-4/h5-8,11-12,25,27-28,33-37,39-40H,9-10H2,1-4H3/t11-,12-,25?,27+,28+,31+,32+/m0/s1
SMILES:  COC(=O)[C@]12Oc3ccc(c(c3C(C2=C(C[C@@H]([C@H]1O)C)O)O)O)c1ccc2c(c1O)C(=O)C1=C(O)C[C@@H]([C@H]([C@@]1(O2)C(=O)OC)O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL1075971
PubChem CID:   n.a.
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO13590 Diploicia canescens Species Caliciaceae Eukaryota n.a. n.a. n.a. PMID[19919064]
NPO13590 Diploicia canescens Species Caliciaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT319 Cell Line B16 Mus musculus IC50 = 280.0 nM PMID[464265]
NPT941 Cell Line HaCaT Homo sapiens IC50 = 3700.0 nM PMID[464265]
NPT115 Organism Mycobacterium tuberculosis H37Ra Mycobacterium tuberculosis H37Ra MIC > 100.0 ug.mL-1 PMID[464266]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC469345 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9939 High Similarity NPC232412
0.9939 High Similarity NPC98667
0.9939 High Similarity NPC86809
0.9755 High Similarity NPC251144
0.9755 High Similarity NPC241387
0.9581 High Similarity NPC477682
0.9581 High Similarity NPC477683
0.9573 High Similarity NPC297195
0.9573 High Similarity NPC291795
0.9573 High Similarity NPC207574
0.931 High Similarity NPC48474
0.9302 High Similarity NPC197972
0.9286 High Similarity NPC154986
0.9102 High Similarity NPC178173
0.9006 High Similarity NPC294149
0.8941 High Similarity NPC241874
0.8908 High Similarity NPC208069
0.8889 High Similarity NPC472620
0.8882 High Similarity NPC217378
0.8844 High Similarity NPC312630
0.8844 High Similarity NPC324220
0.8837 High Similarity NPC469393
0.8837 High Similarity NPC476139
0.883 High Similarity NPC193698
0.882 High Similarity NPC314672
0.881 High Similarity NPC473961
0.8807 High Similarity NPC106700
0.8793 High Similarity NPC476199
0.8793 High Similarity NPC476210
0.8772 High Similarity NPC54903
0.8772 High Similarity NPC286074
0.8772 High Similarity NPC472619
0.8735 High Similarity NPC20530
0.8735 High Similarity NPC146636
0.8735 High Similarity NPC215917
0.8735 High Similarity NPC10754
0.8729 High Similarity NPC470195
0.8729 High Similarity NPC470196
0.8729 High Similarity NPC470200
0.8729 High Similarity NPC470194
0.8729 High Similarity NPC470197
0.8729 High Similarity NPC316274
0.8729 High Similarity NPC282474
0.8729 High Similarity NPC470198
0.8729 High Similarity NPC470193
0.8728 High Similarity NPC476311
0.8728 High Similarity NPC476229
0.8728 High Similarity NPC476152
0.8713 High Similarity NPC472622
0.8708 High Similarity NPC282636
0.8708 High Similarity NPC294863
0.8698 High Similarity NPC472059
0.8693 High Similarity NPC475161
0.8693 High Similarity NPC477860
0.8678 High Similarity NPC162248
0.8671 High Similarity NPC477529
0.8671 High Similarity NPC476159
0.8663 High Similarity NPC102810
0.8663 High Similarity NPC473096
0.8663 High Similarity NPC5319
0.8663 High Similarity NPC326877
0.8663 High Similarity NPC177480
0.8663 High Similarity NPC476216
0.8663 High Similarity NPC473095
0.8655 High Similarity NPC85047
0.8655 High Similarity NPC17274
0.8655 High Similarity NPC469394
0.8655 High Similarity NPC472621
0.8655 High Similarity NPC120857
0.8647 High Similarity NPC63438
0.8647 High Similarity NPC472053
0.8644 High Similarity NPC475656
0.8644 High Similarity NPC475148
0.8639 High Similarity NPC3629
0.8636 High Similarity NPC84494
0.8636 High Similarity NPC245059
0.8636 High Similarity NPC473607
0.8631 High Similarity NPC186113
0.8631 High Similarity NPC125969
0.8623 High Similarity NPC164427
0.8619 High Similarity NPC314459
0.8619 High Similarity NPC470199
0.8614 High Similarity NPC209760
0.8614 High Similarity NPC100134
0.8613 High Similarity NPC74559
0.8606 High Similarity NPC207346
0.8606 High Similarity NPC46564
0.8605 High Similarity NPC225419
0.8605 High Similarity NPC292233
0.8605 High Similarity NPC473094
0.8596 High Similarity NPC75574
0.8596 High Similarity NPC472057
0.8596 High Similarity NPC472051
0.8588 High Similarity NPC470452
0.8588 High Similarity NPC470453
0.8588 High Similarity NPC470448
0.8588 High Similarity NPC473022
0.8588 High Similarity NPC164047
0.8587 High Similarity NPC131405
0.858 High Similarity NPC233978
0.858 High Similarity NPC471976
0.8571 High Similarity NPC63105
0.8563 High Similarity NPC237560
0.8563 High Similarity NPC473113
0.8563 High Similarity NPC217706
0.8563 High Similarity NPC48579
0.8563 High Similarity NPC118128
0.8563 High Similarity NPC259710
0.8563 High Similarity NPC207809
0.8563 High Similarity NPC315619
0.8563 High Similarity NPC477958
0.8563 High Similarity NPC111341
0.8563 High Similarity NPC304207
0.8563 High Similarity NPC476169
0.8563 High Similarity NPC304745
0.8555 High Similarity NPC476146
0.8555 High Similarity NPC158329
0.8555 High Similarity NPC75141
0.8555 High Similarity NPC41598
0.8555 High Similarity NPC20734
0.8555 High Similarity NPC246274
0.8555 High Similarity NPC40089
0.8555 High Similarity NPC55422
0.8555 High Similarity NPC47634
0.8554 High Similarity NPC475790
0.8554 High Similarity NPC217149
0.8554 High Similarity NPC216035
0.8554 High Similarity NPC210597
0.8554 High Similarity NPC138288
0.8547 High Similarity NPC471213
0.8547 High Similarity NPC62444
0.8547 High Similarity NPC87583
0.8547 High Similarity NPC476255
0.8538 High Similarity NPC469395
0.8537 High Similarity NPC191634
0.8531 High Similarity NPC244903
0.8531 High Similarity NPC473729
0.8529 High Similarity NPC97812
0.8529 High Similarity NPC476929
0.8523 High Similarity NPC475246
0.8523 High Similarity NPC46958
0.8523 High Similarity NPC98943
0.8521 High Similarity NPC474373
0.8514 High Similarity NPC213052
0.8514 High Similarity NPC470335
0.8514 High Similarity NPC73899
0.8514 High Similarity NPC17105
0.8514 High Similarity NPC474276
0.8514 High Similarity NPC147363
0.8514 High Similarity NPC470336
0.8506 High Similarity NPC313304
0.8506 High Similarity NPC175429
0.8506 High Similarity NPC138990
0.8506 High Similarity NPC313717
0.8506 High Similarity NPC277532
0.8506 High Similarity NPC103307
0.8506 High Similarity NPC476196
0.8506 High Similarity NPC209550
0.8506 High Similarity NPC315306
0.8503 High Similarity NPC180301
0.8503 High Similarity NPC293286
0.8503 High Similarity NPC236756
0.8503 High Similarity NPC268193
0.8503 High Similarity NPC311579
0.8503 High Similarity NPC326592
0.8503 High Similarity NPC109594
0.8503 High Similarity NPC248793
0.8503 High Similarity NPC203080
0.8503 High Similarity NPC112701
0.8497 Intermediate Similarity NPC8965
0.8497 Intermediate Similarity NPC234497
0.8497 Intermediate Similarity NPC470341
0.8497 Intermediate Similarity NPC472058
0.8497 Intermediate Similarity NPC223413
0.8497 Intermediate Similarity NPC105414
0.8497 Intermediate Similarity NPC63470
0.8497 Intermediate Similarity NPC324522
0.8494 Intermediate Similarity NPC471677
0.8494 Intermediate Similarity NPC474021
0.8494 Intermediate Similarity NPC262038
0.8494 Intermediate Similarity NPC319910
0.8494 Intermediate Similarity NPC278476
0.8494 Intermediate Similarity NPC474023
0.8494 Intermediate Similarity NPC262039
0.8494 Intermediate Similarity NPC295650
0.8494 Intermediate Similarity NPC254412
0.8488 Intermediate Similarity NPC475979
0.8488 Intermediate Similarity NPC62261
0.8488 Intermediate Similarity NPC189689
0.848 Intermediate Similarity NPC472402
0.848 Intermediate Similarity NPC475106
0.848 Intermediate Similarity NPC259834
0.8475 Intermediate Similarity NPC470334
0.8471 Intermediate Similarity NPC472055
0.8466 Intermediate Similarity NPC68381
0.8466 Intermediate Similarity NPC199533
0.8466 Intermediate Similarity NPC470454
0.8466 Intermediate Similarity NPC3718
0.8462 Intermediate Similarity NPC282390
0.8462 Intermediate Similarity NPC246466

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC469345 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8683 High Similarity NPD7075 Discontinued
0.8663 High Similarity NPD7804 Clinical (unspecified phase)
0.8503 High Similarity NPD7096 Clinical (unspecified phase)
0.85 High Similarity NPD7879 Clinical (unspecified phase)
0.8443 Intermediate Similarity NPD6801 Discontinued
0.8343 Intermediate Similarity NPD5402 Approved
0.8314 Intermediate Similarity NPD6959 Discontinued
0.8284 Intermediate Similarity NPD7819 Suspended
0.8276 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8276 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8276 Intermediate Similarity NPD6166 Phase 2
0.8258 Intermediate Similarity NPD7808 Phase 3
0.8235 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8229 Intermediate Similarity NPD7473 Discontinued
0.8214 Intermediate Similarity NPD4380 Phase 2
0.8212 Intermediate Similarity NPD8312 Approved
0.8212 Intermediate Similarity NPD8313 Approved
0.8202 Intermediate Similarity NPD7251 Discontinued
0.8177 Intermediate Similarity NPD8150 Discontinued
0.8156 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8146 Intermediate Similarity NPD6797 Phase 2
0.8144 Intermediate Similarity NPD5403 Approved
0.8101 Intermediate Similarity NPD6559 Discontinued
0.809 Intermediate Similarity NPD7074 Phase 3
0.8081 Intermediate Similarity NPD7768 Phase 2
0.8077 Intermediate Similarity NPD8434 Phase 2
0.807 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8068 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8057 Intermediate Similarity NPD6232 Discontinued
0.8045 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8035 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8034 Intermediate Similarity NPD7054 Approved
0.8034 Intermediate Similarity NPD5844 Phase 1
0.8024 Intermediate Similarity NPD5401 Approved
0.8024 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8023 Intermediate Similarity NPD3817 Phase 2
0.8 Intermediate Similarity NPD6599 Discontinued
0.7989 Intermediate Similarity NPD7472 Approved
0.7989 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7978 Intermediate Similarity NPD3751 Discontinued
0.7964 Intermediate Similarity NPD6799 Approved
0.7958 Intermediate Similarity NPD7435 Discontinued
0.7953 Intermediate Similarity NPD7411 Suspended
0.7943 Intermediate Similarity NPD5494 Approved
0.7907 Intermediate Similarity NPD1934 Approved
0.7874 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7806 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7806 Intermediate Similarity NPD7874 Approved
0.7784 Intermediate Similarity NPD3750 Approved
0.7772 Intermediate Similarity NPD7698 Approved
0.7772 Intermediate Similarity NPD7696 Phase 3
0.7772 Intermediate Similarity NPD7697 Approved
0.7771 Intermediate Similarity NPD3882 Suspended
0.7766 Intermediate Similarity NPD7783 Phase 2
0.7766 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7759 Intermediate Similarity NPD1465 Phase 2
0.7759 Intermediate Similarity NPD8455 Phase 2
0.7759 Intermediate Similarity NPD2801 Approved
0.7755 Intermediate Similarity NPD8151 Discontinued
0.7753 Intermediate Similarity NPD3787 Discontinued
0.7732 Intermediate Similarity NPD8320 Phase 1
0.7732 Intermediate Similarity NPD8319 Approved
0.773 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD3749 Approved
0.7711 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7708 Intermediate Similarity NPD6778 Approved
0.7708 Intermediate Similarity NPD6777 Approved
0.7708 Intermediate Similarity NPD6776 Approved
0.7708 Intermediate Similarity NPD6781 Approved
0.7708 Intermediate Similarity NPD6782 Approved
0.7708 Intermediate Similarity NPD6780 Approved
0.7708 Intermediate Similarity NPD6779 Approved
0.7706 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7704 Intermediate Similarity NPD7701 Phase 2
0.768 Intermediate Similarity NPD3818 Discontinued
0.768 Intermediate Similarity NPD7228 Approved
0.7665 Intermediate Similarity NPD1549 Phase 2
0.7644 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7641 Intermediate Similarity NPD7870 Phase 2
0.7641 Intermediate Similarity NPD7871 Phase 2
0.763 Intermediate Similarity NPD3226 Approved
0.7604 Intermediate Similarity NPD7699 Phase 2
0.7604 Intermediate Similarity NPD7700 Phase 2
0.7602 Intermediate Similarity NPD2532 Approved
0.7602 Intermediate Similarity NPD2533 Approved
0.7602 Intermediate Similarity NPD2534 Approved
0.7588 Intermediate Similarity NPD7801 Approved
0.7574 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD1512 Approved
0.7545 Intermediate Similarity NPD2935 Discontinued
0.7529 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD2346 Discontinued
0.7485 Intermediate Similarity NPD3748 Approved
0.7485 Intermediate Similarity NPD2799 Discontinued
0.7471 Intermediate Similarity NPD4628 Phase 3
0.7456 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7449 Intermediate Similarity NPD6823 Phase 2
0.7448 Intermediate Similarity NPD6534 Approved
0.7448 Intermediate Similarity NPD6535 Approved
0.7442 Intermediate Similarity NPD1511 Approved
0.744 Intermediate Similarity NPD1551 Phase 2
0.744 Intermediate Similarity NPD2796 Approved
0.7427 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7414 Intermediate Similarity NPD920 Approved
0.7412 Intermediate Similarity NPD2800 Approved
0.741 Intermediate Similarity NPD6355 Discontinued
0.7401 Intermediate Similarity NPD37 Approved
0.7389 Intermediate Similarity NPD5537 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD6234 Discontinued
0.7389 Intermediate Similarity NPD919 Approved
0.7381 Intermediate Similarity NPD1510 Phase 2
0.7374 Intermediate Similarity NPD4965 Approved
0.7374 Intermediate Similarity NPD4966 Approved
0.7374 Intermediate Similarity NPD4967 Phase 2
0.7368 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7366 Intermediate Similarity NPD5953 Discontinued
0.7351 Intermediate Similarity NPD7286 Phase 2
0.7349 Intermediate Similarity NPD4060 Phase 1
0.7345 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD7240 Approved
0.731 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD1247 Approved
0.7305 Intermediate Similarity NPD5124 Phase 1
0.7305 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7283 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD1607 Approved
0.7262 Intermediate Similarity NPD6651 Approved
0.7246 Intermediate Similarity NPD1240 Approved
0.7241 Intermediate Similarity NPD7390 Discontinued
0.7235 Intermediate Similarity NPD6099 Approved
0.7235 Intermediate Similarity NPD6100 Approved
0.7232 Intermediate Similarity NPD7458 Discontinued
0.7229 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7229 Intermediate Similarity NPD2313 Discontinued
0.7229 Intermediate Similarity NPD6798 Discontinued
0.7229 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD3926 Phase 2
0.7228 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7225 Intermediate Similarity NPD6190 Approved
0.7219 Intermediate Similarity NPD7097 Phase 1
0.72 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD6233 Phase 2
0.7174 Intermediate Similarity NPD5711 Approved
0.7174 Intermediate Similarity NPD5710 Approved
0.7174 Intermediate Similarity NPD7229 Phase 3
0.7168 Intermediate Similarity NPD7003 Approved
0.7143 Intermediate Similarity NPD7685 Pre-registration
0.7129 Intermediate Similarity NPD7584 Approved
0.7121 Intermediate Similarity NPD8285 Discontinued
0.712 Intermediate Similarity NPD8127 Discontinued
0.712 Intermediate Similarity NPD7199 Phase 2
0.711 Intermediate Similarity NPD1243 Approved
0.7108 Intermediate Similarity NPD6832 Phase 2
0.7108 Intermediate Similarity NPD4908 Phase 1
0.7105 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD5762 Approved
0.7093 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7093 Intermediate Similarity NPD5763 Approved
0.7092 Intermediate Similarity NPD4360 Phase 2
0.7092 Intermediate Similarity NPD4363 Phase 3
0.7086 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7076 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD8404 Phase 2
0.7066 Intermediate Similarity NPD4625 Phase 3
0.7062 Intermediate Similarity NPD6273 Approved
0.7041 Intermediate Similarity NPD1613 Approved
0.7041 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD5408 Approved
0.7035 Intermediate Similarity NPD5405 Approved
0.7035 Intermediate Similarity NPD5404 Approved
0.7035 Intermediate Similarity NPD5406 Approved
0.7024 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7024 Intermediate Similarity NPD7985 Registered
0.7021 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD8366 Approved
0.7014 Intermediate Similarity NPD7907 Approved
0.7006 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7005 Intermediate Similarity NPD2403 Approved
0.7 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.6994 Remote Similarity NPD2344 Approved
0.6991 Remote Similarity NPD8067 Phase 3
0.6983 Remote Similarity NPD1653 Approved
0.698 Remote Similarity NPD7680 Approved
0.6977 Remote Similarity NPD7033 Discontinued
0.6971 Remote Similarity NPD7930 Approved
0.6971 Remote Similarity NPD7982 Clinical (unspecified phase)
0.6971 Remote Similarity NPD8166 Discontinued
0.6966 Remote Similarity NPD5049 Phase 3
0.6964 Remote Similarity NPD7095 Approved
0.6963 Remote Similarity NPD8368 Discontinued
0.6954 Remote Similarity NPD6213 Phase 3
0.6954 Remote Similarity NPD6212 Phase 3
0.6954 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6954 Remote Similarity NPD2424 Discontinued
0.695 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6948 Remote Similarity NPD5619 Clinical (unspecified phase)
0.694 Remote Similarity NPD4288 Approved
0.6936 Remote Similarity NPD2438 Suspended

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data